Text Size
1060 studies found for:    Endometrial Cancer: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Suspended Preliminary Study of Endometrial Hyperplasia-Groundwork for a Study to Define Precursors of Endometrial Cancer
Conditions: Endometrial Hyperplasia;   Endometrial Carcinoma
Intervention:
22 Completed Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: letrozole
23 Recruiting Telephone Follow-up After Treatment for Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Other: Telephone Follow-up
24 Completed Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer
Condition: Endometrial Carcinoma
Intervention: Drug: carboplatin, paclitaxel, and bevacizumab
25 Withdrawn Study of FP-1039 in Subjects With Endometrial Cancers
Condition: Endometrial Cancers With FGFR2 Mutations
Intervention: Drug: FP-1039
26 Unknown † Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Lymphedema;   Vulvar Cancer
Interventions: Other: questionnaire administration;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment;   Procedure: study of high risk factors;   Procedure: therapeutic conventional surgery;   Procedure: therapeutic laparoscopic surgery;   Procedure: therapeutic lymphadenectomy
27 Completed Endometrial Polyps: Pathophysiology and Clinical Consequences
Conditions: Endometrial Polyp;   Endometrial Cancer
Intervention: Procedure: Hysteroscopic resection of endometrial polyps. (TCRP)
28 Completed Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Conditions: Endometrial Cancer;   Endometrial Neoplasms
Intervention: Drug: XL147 (SAR245408)
29 Completed Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: Tc 99m EC20
30 Active, not recruiting A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
Condition: Endometrial Carcinoma
Intervention: Drug: GDC-0980
31 Recruiting Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer
Condition: Stage III-IV or Recurrent Endometrial Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8 cycles
32 Recruiting Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Endometrial Adenosquamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Interventions: Drug: dasatinib;   Drug: carboplatin;   Drug: paclitaxel;   Other: laboratory biomarker analysis
33 Recruiting Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
Condition: Endometrial Cancer
Intervention: Behavioral: Questionnaire
34 Active, not recruiting Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: ridaforolimus;   Genetic: gene expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
35 Recruiting Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer
Conditions: Endometrial Cancer;   Gastrointestinal Complications;   Radiation Toxicity;   Urinary Complications
Intervention: Radiation: 45 Gy/25 fractions
36 Completed Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: danazol
37 Completed Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Condition: Recurrent Endometrial Carcinoma
Interventions: Drug: gefitinib;   Other: laboratory biomarker analysis
38 Recruiting Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms
Conditions: Breast Cancer;   Endometrial Cancer
Interventions: Other: HLA vaginal gel (HyaloGYN®),;   Behavioral: questionnaires
39 Completed AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)
Condition: Endometrial Cancer
Intervention: Drug: ridaforolimus
40 Enrolling by invitation A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma
Condition: Recurrent Endometrial Cancer
Intervention: Drug: Lapatinib and ixempra
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years